Integral medication review with follow up program to chronic and poymedicated patients. Pilot Program in patients with type 2 Diabetes Mellitus
DOI:
https://doi.org/10.60103/phc.v24i6.791Keywords:
Community pharmacy; Community pharmacy services; Medication review with follow up serviceAbstract
Introduction: Basque community pharmacy has a long tradition of collaborating with Basque health authorities. In May 2017, a collaboration agreement was signed between the Department of Health and the three Basque Pharmaceutical Associations "for the implementation of a Pilot Program for Medication review with follow up service for chronic polymedicated patients".
Method: The medication review with follow up service was carried out in pharmacies of three integrated health organizations in Alava, Bizkaia and Gipuzkoa. 18 pharmacies participated with 7 patients each. Inclusion criteria: patients with type 2 diabetes who were taking 8 or more medicines. During the 12 months of the study, three points were analyzed: baseline (V1), 6 months (V2) and at the end of the study (V3).
Results: Of the 127 initially planned patients, 87 completed the study. No significant differences were obtained in the HbA1c value between baseline and the end. In contrast, the number of uncontrolled health problems decreased by 47% (p=0.001) without changing the number of medications. The most frequent DRPs in V3 were insufficient knowledge of the medication (34%) and lack of adherence (19%). Both, knowledge and adherence (p<0.001) and quality of life (p<0.05) improved.
Conclusions: Although the program has not had an impact on the value of HbA1c, it has contributed to controlling other health problems, as well as adherence, knowledge about medications and the quality of life of patients.
Downloads
References
Gastelurrutia MA, Larrañaga B, Garay A, Echeveste FA. Intervención desde la farmacia comunitaria a pacientes atendidos en los servicios de ayuda domiciliaria municipal. FARMACÉUTICOS COMUNITARIOS 2010; 2(1): 15-20
Osakidetza. Memoria del Plan del SIDA y Enfermedades de Transmisión Sexual. 2020. https://www.osakidetza.euskadi.eus/contenidos/informacion/osk_osaesk_salud_sex_vih/es_def/adjuntos/Memoria_VIH_2020_v2.pdf (Acceso, octubre 2021)
Encuesta de Salud de la CAPV 2018. Departamento de Salud del Gobierno Vasco. https://www.euskadi.eus/informacion/encuesta-de-salud-2017-2018/web01-a3osag17/es/ (Acceso, marzo 2022)
Guía de diabetes tipo 2 para clínicos: Recomendaciones de la redGDPS. Fundación redGDPS,2018. https://www.redgdps.org/gestor/upload/colecciones/Guia%20DM2_web.pdf (Acceso, marzo 2022)
Huang ES. Management of diabetes mellitus in older people with comorbidities. BMJ. 2016 Jun 15;353:i2200. doi: 10.1136/bmj.i2200
Gómez-Huelgas R, Gómez Peralta F, Rodríguez Mañas L, Formiga F, Puig Domingo M, Mediavilla Bravo JJ, et al. Tratamiento de la diabetes tipo 2 en el paciente anciano. Med Clin (Barc). 2013;140(3):134.e1-134.e12. doi: 10.1016/j.medcli.2012.10.003.
Jódar-Sánchez F, Malet-Larrea A, Martín JJ, García-Mochón L, López del Amo MP, Martínez-Martínez F, et al. Cost-Utility Analysis of a Medication Review with Follow-Up Service for Older Adults with Polypharmacy in Community Pharmacies in Spain: The conSIGUE Program. PharmacoEconomics 2015; 33(6):599-610. doi: 10.1007/s40273-015-0270-2
Wali H, Hudani Z, Wali S, Mercer K, Grindrod K. A systematic review of interventions to improve medication information for low health literate populations. Res Social Adm Pharm. 2016;12(6):830-864. doi: 10.1016/j.sapharm.2015.12.001.
Rajiah K, Sivarasa S, Maharajan MK. Impact of Pharmacists' Interventions and Patients' Decision on Health Outcomes in Terms of Medication Adherence and Quality Use of Medicines among Patients Attending Community Pharmacies: A Systematic Review. Int J Environ Res Public Health. 2021 Apr 21;18(9):4392. doi: 10.3390/ijerph18094392.
The World Health Report 2002: Reducing Risks, Promoting Healthy Life. Geneva, World Health Organization, 2002. https://apps.who.int/iris/bitstream/handle/10665/42510/WHR_2002.pdf?sequence=1 (Acceso, marzo 2022)
Entrevista Clínica. Manual de estrategias prácticas. Francesc Borrell i Carrió. Editorial: SEMFYC. https://www.semfyc.es/wp-content/uploads/2016/05/EntrevistaClinica_Borrell.pdf (Acceso, marzo 2022)
Sáez-Benito L, Fernandez-Llimos F, Feletto E, Gastelurrutia MA, Martinez-Martinez F, Benrimoj SI. Evidence of the clinical effectiveness of cognitive pharmaceutical services for aged patients. Age Ageing. 2013;42(4):442–9. doi: 10.1093/ageing/aft045
Varas-Doval R, Saéz-Benito L, Gastelurrutia MA, Benrimoj SI, Garcia-Cardenas V, Martinez-Martínez F. Systematic review of pragmatic randomised control trials assessing the effectiveness of professional pharmacy services in community pharmacies. BMC Health Serv Res. 2021 Feb 17;21(1):156. doi: 10.1186/s12913-021-06150-8.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Nerea Ullibarri, Miguel Ángel Gastelurrutia, Flavia Erazo, Milagros López de Ocáriz, Amaia Martiarena, Diez, Blanca, Miriam Sáenz de Santamaria, Villacorta, Mercedes, Juan del-Arco, Goyenechea, Estibaliz, Braceras, Leire, Jon Iñaki Betolaza
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
La revista Pharmaceutical Care España se publica bajo una licencia «Creative Commons, Reconocimiento, No Comercial y Compartir Igual 4.0 Internacional» (CC BY-NC-SA 4.0)», que permite a otros compartir el trabajo con un reconocimiento de la autoría del trabajo y la publicación inicial en esta revista (con excepción de los usos comerciales).
Los autores que publican en esta revista están de acuerdo con los siguientes términos:a) Los autores conservan los derechos de autor (derechos morales) y garantizan a la revista el derecho de ser el primer soporte documental publicado del trabajo.
b) Se permite y anima a los autores a difundir la versión del trabajo revisado por pares y aceptada para su publicación (por ejemplo, en repositorios institucionales o temáticos), recomendando hacerlo con la versión final del editor “pdf”, “html” o “xml”).
